» Articles » PMID: 26496429

Influence of Molecular Size on Tissue Distribution of Antibody Fragments

Overview
Journal MAbs
Date 2015 Oct 27
PMID 26496429
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

Biodistribution coefficients (BC) allow estimation of the tissue concentrations of proteins based on the plasma pharmacokinetics. We have previously established the BC values for monoclonal antibodies. Here, this concept is extended by development of a relationship between protein size and BC values. The relationship was built by deriving the BC values for various antibody fragments of known molecular weight from published biodistribution studies. We found that there exists a simple exponential relationship between molecular weight and BC values that allows the prediction of tissue distribution of proteins based on molecular weight alone. The relationship was validated by a priori predicting BC values of 4 antibody fragments that were not used in building the relationship. The relationship was also used to derive BC50 values for all the tissues, which is the molecular weight increase that would result in 50% reduction in tissue uptake of a protein. The BC50 values for most tissues were found to be ~35 kDa. An ability to estimate tissue distribution of antibody fragments based on the BC vs. molecular size relationship established here may allow better understanding of the biologics concentrations in tissues responsible for efficacy or toxicity. This relationship can also be applied for rational development of new biotherapeutic modalities with optimal biodistribution properties to target (or avoid) specific tissues.

Citing Articles

FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical models.

Weeden T, Picariello T, Quinn B, Spring S, Shen P, Qiu Q Commun Med (Lond). 2025; 5(1):22.

PMID: 39827287 PMC: 11742727. DOI: 10.1038/s43856-025-00733-w.


Pulmonary Pharmacokinetics of Antibody and Antibody Fragments Following Systemic and Local Administration in Mice.

Jagdale P, Verma A, Shah D Pharmaceutics. 2024; 16(10).

PMID: 39458591 PMC: 11510323. DOI: 10.3390/pharmaceutics16101259.


Developability considerations for bispecific and multispecific antibodies.

Amash A, Volkers G, Farber P, Griffin D, Davison K, Goodman A MAbs. 2024; 16(1):2394229.

PMID: 39189686 PMC: 11352713. DOI: 10.1080/19420862.2024.2394229.


Single-Domain Antibodies as Antibody-Drug Conjugates: From Promise to Practice-A Systematic Review.

Medina Perez V, Baselga M, Schuhmacher A Cancers (Basel). 2024; 16(15).

PMID: 39123409 PMC: 11311928. DOI: 10.3390/cancers16152681.


Non-invasive strategy: Developing a topical IL-4Rα-specific nanobody for the treatment of allergic airway diseases.

Ahn T, Lee D, Kim G, Kim J, Park J, Cho H Mater Today Bio. 2024; 27:101148.

PMID: 39108557 PMC: 11301380. DOI: 10.1016/j.mtbio.2024.101148.


References
1.
Venturoli D, Rippe B . Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability. Am J Physiol Renal Physiol. 2005; 288(4):F605-13. DOI: 10.1152/ajprenal.00171.2004. View

2.
Sandstrom K, Haylock A, Spiegelberg D, Qvarnstrom F, Wester K, Nestor M . A novel CD44v6 targeting antibody fragment with improved tumor-to-blood ratio. Int J Oncol. 2012; 40(5):1525-32. DOI: 10.3892/ijo.2012.1352. View

3.
Shah D, Betts A . Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human. J Pharmacokinet Pharmacodyn. 2011; 39(1):67-86. DOI: 10.1007/s10928-011-9232-2. View

4.
Shah D, Betts A . Antibody biodistribution coefficients: inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human. MAbs. 2013; 5(2):297-305. PMC: 3893240. DOI: 10.4161/mabs.23684. View

5.
Garg A, Balthasar J . Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice. J Pharmacokinet Pharmacodyn. 2007; 34(5):687-709. DOI: 10.1007/s10928-007-9065-1. View